PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in C2C Wealth Management, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which C2C Wealth Management, LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2025 Q4)
Avg. % of fund
0.07%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 23,020 — 0% 0.12% $137K $5.95
2025 Q3 ADDED 23,020 +2,400 +11.6% 0.10% $122K $5.31
2025 Q2 ADDED 20,620 +5,470 +36.1% 0.06% $71K $3.43
2025 Q1 ADDED 15,150 +3,150 +26.2% 0.04% $45K $2.96
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to C2C Wealth Management, LLC Holdings